Document Details

MGEN $9.02   $ (0.03) (0.33)%
Document Details

Filing Type

8-K (SEC's EDGAR System)

Company Miragen Therapeutics (Boulder, CO)
Event Date 2/13/2017
Filing Date 2/13/2017

Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Completion of Acquisition or Disposition of Assets; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Material Modification to Rights of Security Holders; Changes in Registrant's Certifying Accountant; Changes in Control of Registrant; Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics; and Financial Statements and Exhibits.
Download

File Section(s)

  1. 8-K
  2. EX-3.1
  3. EX-3.2
  4. EX-3.3
  5. EX-3.4
  6. EX-14.1
  7. EX-16.1
  8. EX-99.1
  9. EX-99.2

Note: This document was filed with the SEC in HTML format, as allowed by the recent EDGAR system modernization. S&P cannot take responsibility for its appearance, layout, or legibility.